|
Treatment guidelines for opioid and alcohol dependence pharmacotherapy
|
Training Initiative
|
SAMHSA
|
NIDA, NIAAA
|
Development and publication of guidelines for health care providers on how to treat opioid and alcohol dependence.
|
|
Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)
|
Research Initiative
|
CDC
|
NIDDK
|
Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) is a multi-center clinical research study examining the safety and efficacy of three treatment options for type 2 diabetes in the pediatric population. TODAY was initiated due to the increase in type 2 diabetes in children and adolescents, which itself is linked to the rise in obesity.
|
|
Trends in Health and Aging
|
Resource Development
|
CDC
|
NIA
|
A data archive of trend tables with health indicators displayed over time and by age, sex, and race/ethnicity. A Web-based tool developed and maintained by the National Center for Health Statistics, attempts to connect consumers of information on health and aging with suppliers of such data by providing user-friendly access to up-to-date information on the health and well-being of older Americans.
|
|
Trends in hormone concentrations in U.S. men and relationship to endocrine disrupting chemicals in the NHANES population
|
Research Initiative
|
CDC
|
NCI
|
An examination of serum hormone levels of men in the NHANES population to determine whether levels have declined over time and whether they correlate with serum levels of endocrine disrupting chemicals.
|
|
Tribal Epidemiology Centers Program
|
Research Initiative
|
IHS
|
NIMHD
|
To develop Epidemiology Centers and public health infrastructure for AI/AN communities.
|
|
Tribal Health Research Advisory Council (HRAC)
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NIMHD
|
To support the activities of the Council, including obtaining input from tribal leaders on health research priorities and needs, and dissemination of information.
|
|
Tuberculosis (TB) Diagnostics Research Forum
|
Other
|
CDC
|
NIAID
|
The purpose of the Forum is to communicate, coordinate, and collaborate to address issues of Tuberculosis (TB) diagnostics, especially drug susceptibility testing (DST) for new drugs and regimens. The initial focus was to bring together researchers, clinicians, clinical trial groups, government, and non‐government organizations with both the drug and diagnostic industry to advance the field of pyrazinamide (PZA) DST to meet the needs of clinical trials scheduled for 2013. In addition, the Forum will expand to other drugs including FQ and new anti-tuberculosis drugs in the pipeline.
|
|
Tuberculosis (TB) Therapeutics Research Coordination Forum
|
Other
|
CDC
|
NIAID
|
The purpose of the Tuberculosis (TB) Therapeutics Research Coordination Forum (“the Forum”) is to support and sustain discussion, information sharing, and decision making to coordinate clinical trials of new Tuberculosis (TB) drug combinations. The overall goal is to advance new therapies rapidly and cost-effectively while maintaining the highest standards of scientific rigor. The Forum will work to coordinate planning among the major non-commercial sponsors and their research groups to ensure rapid and efficient Phase II evaluations of drug combinations.
|
|
U.S. Department of Health and Human Services -- Overview of Violence Against Women Activities Report 2010-2011
|
Other
|
CDC, CMS, HRSA, IHS
|
NIDA, NIA, NIAAA, NICHD, NIMH, NINR
|
This report is prepared by representatives of all HHS agencies involved in activities focused on prevention of violence against women.
|
|
U.S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
OD/OSP, NCI, NHGRI, NIBIB, NIEHS
|
The NSET Subcommittee and NEHI Working Group provide leadership in establishing the national nanotechnology environmental, health, and safety research agenda and in communicating data and information related to environmental and health aspects of nanotechnology between National Nanotechnology Initiative (NNI) agencies and with the public. NNI activities support the development of new tools and methods required for the research that will enable risk analysis and assist in regulatory decision-making. NNI agencies engage and interact with regional, state, and local groups, educational institutions, industry-supported groups, and non-governmental organizations to enhance the impact and value of NNI efforts and to provide a collaborative approach.
|